These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 17173262

  • 21. Arterial hypertension and left ventricular hypertrophy in hemodialysis patients.
    Paoletti E, Cannella G.
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S46-51. PubMed ID: 12227726
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Left ventricular myocardial hypertrophy after transplantation of the kidney: risk factors and possible regress].
    Tomilina NA, Gendlin GE, Zhidkova DA, Tronina OA, Fedorova ND.
    Ter Arkh; 2009 Jul; 81(8):42-8. PubMed ID: 19799199
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA, Vyssoulis GP, Karpanou EA, Marinakis AG, Barbetseas JD, Zervoudaki AI, Cokkinos DV, Stefanadis CI.
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [Abstract] [Full Text] [Related]

  • 28. Influence of ACE inhibition on left ventricular hypertrophy.
    Agabiti-Rosei E, Muiesan ML.
    Br J Clin Pract Suppl; 1996 Jul; 84():17-22. PubMed ID: 8994997
    [Abstract] [Full Text] [Related]

  • 29. [Heart failure in chronic kidney disease: from epidemiology to therapy].
    Zamboli P, De Nicola L, Minutolo R, Stanzione G, Bertino V, Sosio R, De Luca A, Crivaro M, Tassinario S, Conte G.
    G Ital Nefrol; 2007 Jul; 24(6):574-83. PubMed ID: 18278761
    [Abstract] [Full Text] [Related]

  • 30. Advancing chronic kidney disease care: new imperatives for recognition and intervention.
    Szromba C, Thies MA, Ossman SS.
    Nephrol Nurs J; 2002 Dec; 29(6):547-59; quiz 560-1. PubMed ID: 12596604
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Managing a fateful alliance: anaemia and cardiovascular outcomes.
    Eckardt KU.
    Nephrol Dial Transplant; 2005 Jun; 20 Suppl 6():vi16-20. PubMed ID: 15958821
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The effects of vitamin D therapy on left ventricular structure and function - are these the underlying explanations for improved CKD patient survival?
    Covic A, Voroneanu L, Goldsmith D.
    Nephron Clin Pract; 2010 Jun; 116(3):c187-95. PubMed ID: 20606478
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prognostic value of combined target-organ damage in patients with essential hypertension.
    Carpinella G, Pagano G, Buono F, Petitto M, Guarino G, Orefice G, Rengo G, Trimarco B, Morisco C.
    Am J Hypertens; 2015 Jan; 28(1):127-34. PubMed ID: 24936579
    [Abstract] [Full Text] [Related]

  • 39. Is regression of left ventricular hypertrophy in maintenance hemodialysis patients possible?
    Bossola M, Tazza L, Vulpio C, Luciani G.
    Semin Dial; 2008 Jan; 21(5):422-30. PubMed ID: 18764802
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of subclinical target organ damage for risk assessment and treatment in the hypertensive patients: left ventricular hypertrophy.
    Agabiti-Rosei E, Muiesan ML, Salvetti M.
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S104-8. PubMed ID: 16565230
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.